Related Experiment Video
Updated: Nov 3, 2025

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
Published on: November 24, 2021
Graphene Oxide Topical Administration: Skin Permeability Studies.
Filipa A L S Silva1,2, Raquel Costa-Almeida1,2, Licínia Timochenco3
1i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 208, 4200-180 Porto, Portugal.
Graphene oxide nanoparticles show promise for topical drug delivery and photothermal therapy due to their skin permeation and mild heating properties. They are stable, non-toxic to skin cells, and offer advantages over conventional treatments.
Area of Science:
- Materials Science
- Nanotechnology
- Dermatology
Background:
- Nanostructured carriers enhance dermatological drug delivery.
- Graphene oxide (GO) possesses properties suitable for pharmaceutical applications.
Purpose of the Study:
- To evaluate graphene oxide nanoparticles (GOn) for topical administration and photothermal therapy.
- To assess GOn skin permeation, stability, and biocompatibility.
Main Methods:
- Characterization of GOn size, charge, and stability.
- In vitro skin permeation studies.
- Photothermal effect assessment and cytotoxicity testing on human skin fibroblasts.
Main Results:
- GOn (197.6 nm) demonstrated stability in water for over 6 months.
- 55.5% GOn mass permeated skin within 6 hours; no permeation for larger graphite particles.
- GOn exhibited mild photothermal heating (up to 45.7 °C) and showed no toxicity to skin cells.
Conclusions:
- Graphene oxide nanoparticles are effective for topical delivery and photothermal therapy.
- GOn offers a safe and stable nanocarrier for dermatological applications.
More Related Videos
08:57Scalable Syntheses of Graphene Oxide and Reduced Graphene Oxide using Cascade Design Oxidation and Highly Basic Reduction Reactions
Published on: July 3, 2025
10:17Preparation and Characterization of Graphene-Based 3D Biohybrid Hydrogel Bioink for Peripheral Neuroengineering
Published on: May 16, 2022